Cryonics technology seeks to cryopreserve the anatomical basis of the mind so that future medicine can restore legally dead cryonics patients to life, youth, and health. Most cryonics patients experience varying degrees of ischemia and reperfusion injury. Neurons can survive ischemia and reperfusion injury more than is generally believed, but blood vessels are more vulnerable, and such injury can impair perfusion of vitrifying cryoprotectant solution intended to eliminate ice formation in the brain. Forms of vascular and neuronal damage are reviewed, along with means of mitigating that damage. Recommendations are also made for preventing such damage.
Get full access to this article
View all access options for this article.
References
1.
BestBP. Scientific justification of cryonics practice. Rejuvenation Res, 2008; 11:493–503.
Vanden HoekTL, ShaoZ, LiC, ZakR, SchumackerPT, BeckerLB. Reperfusion injury on cardiac myocytes after simulated ischemia. Am J Physiol, 1996; 27:H1334–H1341.
4.
Vanden HoekTL, ShaoZ, LiC, SchumackerPT, BeckerLB. Mitochondrial electron transport can become a significant source of oxidative injury in cardiomyocytes. J Mol Cell Cardiol, 1997; 29:2441–2450.
5.
AronowskiJ, StrongR, GrottaJC. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats. J Cereb Blood Flow Metab, 1997; 17:1048–1056.
6.
Vanden HoekTL, LiC, ShaoZ, SchumackerPT, BeckerLB. Significant levels of oxidants are generated by isolated cardiomyocytes during ischemia prior to reperfusion. J Mol Cell Cardiol, 1997; 29:2571–2583.
7.
ZweierJL, KuppusamyP, WilliamsR, RayburnBK, SmithD, WeisfeldtML, FlahertyJT. Measurement and characterization of postischemic free radical generation in the isolated perfused heart. J Biol Chem, 1989; 15,264:18890–18895.
8.
LiuB, TewariAK, ZhangL, Green-ChurchKB, ZweierJL, ChenYR, HeG. Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: Mitochondria as the major target. Biochim Biophys Acta, 2009; 1794:476–485.
9.
Di LisaF, KaludercicN, CarpiA, MenabòR, GiorgioM. Mitochondria and vascular pathology. Pharmacol Rep, 2009; 61:123–130.
10.
LiJM, ShahAM. Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells. J Biol Chem., 2002May31277,22:19952–60.
SzabóC, IschiropoulosH, RadiR. Peroxynitrite: Biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov, 2007; 6:662–680.
13.
WuS, TamakiN, NagashimaT, YamaguchiM. Reactive oxygen species in reoxygenation injury of rat brain capillary endothelial cells. Neurosurgery, 1998; 43:577–583discussion 584.
14.
MiclescuA, SharmaHS, MartijnC, WiklundL. Methylene blue protects the cortical blood-brain barrier against ischemia/reperfusion-induced disruptions. Crit Care Med, 2010; 38:2199–2206.
GourdinMJ, BreeB, De KockM. The impact of ischaemia-reperfusion on the blood vessel. Eur J Anaesthesiol, 2009; 26:537–547
17.
KurodaS, SiesjöBK. Reperfusion damage following focal ischemia: Pathophysiology and therapeutic windows. Clin Neurosci, 1997; 4:199–212.
18.
del ZoppoGJ, Schmid-SchönbeinGW, MoriE, CopelandBR, ChangCM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke, 1991; 22:1276–1283.
19.
MoriE, del ZoppoGJ, ChambersJD, CopelandBR, ArforsKE. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke, 1992; 23:712–718.
20.
PearsonMJ, LipowskyHH. Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery. Am J Physiol Heart Circ Physiol, 2000; 279:H1460–H1471.
21.
RitterL, FunkJ, SchenkelL, TiptonA, DowneyK, WilsonJ, CoullB, McDonaghP. Inflammatory and hemodynamic changes in the cerebral microcirculation of aged rats after global cerebral ischemia and reperfusion. Microcirculation, 2008; 15:297–310.
22.
GarciaJH, LiuKF, YoshidaY, ChenS, LianJ. Brain microvessels: Factors altering their patency after the occlusion of a middle cerebral artery (Wistar rat)Am J Pathol, 1994; 145:728–740.
23.
DawsonDA, RuetzlerCA, HallenbeckJM. Temporal impairment of microcirculatory perfusion following focal cerebral ischemia in the spontaneously hypertensive rat. Brain Res, 1997; 749:200–208.
24.
SageJI, Van UitertRL, DuffyTE. Early changes in blood brain barrier permeability to small molecules after transient cerebral ischemia. Stroke, 1984; 15:46–50.
25.
KimGW, LewénA, CopinJ, WatsonBD, ChanPH. The cytosolic antioxidant, copper/zinc superoxide dismutase, attenuates blood-brain barrier disruption and oxidative cellular injury after photothrombotic cortical ischemia in mice. Neuroscience, 2001; 105:1007–1018.
26.
BucciM, RoviezzoF, PosadasI, YuJ, ParenteL, SessaWC, IgnarroLJ, CirinoG. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci USA, 2005; 18,102:904–908.
27.
MayhanWG, DidionSP. Glutamate-induced disruption of the blood-brain barrier in rats. Role of nitric oxide. Stroke, 1996; 27:965–969discussion 970.
ArmsteadWM, MirroR, ThelinOP, ShibataM, ZuckermanSL, ShanklinDR, BusijaDW, LefflerCW. Polyethylene glycol superoxide dismutase and catalase attenuate increased blood-brain barrier permeability after ischemia in piglets. Stroke, 1992; 23:755–762.
30.
SumaginR, LomakinaE, SareliusIH. Leukocyte-endothelial cell interactions are linked to vascular permeability via ICAM-1-mediated signaling. Am J Physiol Heart Circ Physiol, 2008; 295:H969–H977.
31.
SlivkaA, MurphyE, HorrocksL. Cerebral edema after temporary and permanent middle cerebral artery occlusion in the rat. Stroke, 1995; 26:1061–1065discussion 1065–1066.
32.
GotohO, AsanoT, KoideT, TakakuraK. Ischemic brain edema following occlusion of the middle cerebral artery in the rat. I: The time courses of the brain water, sodium and potassium contents and blood-brain barrier permeability to 125I-albumin. Stroke, 1985; 16:101–109.
33.
RosenbergGA, EstradaEY, DencoffJE. Matrix metalloproteinases and TIMPs are associated with blood–brain barrier opening after reperfusion in rat brain. Stroke, 1998; 29:2189–2195.
HeZJ, HuangZT, ChenXT, ZouZJ. Effects of matrix metalloproteinase 9 inhibition on the blood brain barrier and inflammation in rats following cardiopulmonary resuscitation. Chin Med J (Engl), 2009; 122:2346–2351.
37.
ShabanzadehAP, ShuaibA, WangCX. Simvastatin reduced ischemic brain injury and perfusion deficits in an embolic model of stroke. Brain Res, 2005; 25,1042:1–5.
LiuXS, ZhangZG, ZhangL, MorrisDC, KapkeA, LuM, ChoppM. Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. J Cereb Blood Flow Metab, 2006; 26:787–796.
40.
van BruggenN, ThibodeauxH, PalmerJT, LeeWP, FuL, CairnsB, TumasD, GerlaiR, WilliamsSP, van Lookeren CampagneM, FerraraN. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest, 1999; 104:1613–1620.
41.
ShuaibA, Xu WangC, YangT, NoorR. Effects of nonpeptide V(1) vasopressin receptor antagonist SR-49059 on infarction volume and recovery of function in a focal embolic stroke model. Stroke, 2002; 33:3033–3037.
42.
GunnarsonE, SongY, KowalewskiJM, BrismarH, BrinesM, CeramiA, AnderssonU, ZeleninaM, AperiaA. Erythropoietin modulation of astrocyte water permeability as a component of neuroprotection. Proc Natl Acad Sci USA, 2009; 106:1602–1607.
YepesM, RousselBD, AliC, VivienD. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci, 2009; 32:48–55.
46.
TakahashiM, MacdonaldRL. Vascular aspects of neuroprotection. Neurol Res, 2004; 26:862–869.
47.
CumminsRO, EisenbergMS, HallstromAP, LitwinPE. Survival of out-of-hospital cardiac arrest with early initiation of cardiopulmonary resuscitation. Am J Emerg Med, 1985; 3:114–119.
48.
HerlitzJ, EngdahlJ, SvenssonL, YoungM, AngquistKA, HolmbergS. Can we define patients with no chance of survival after out-of-hospital cardiac arrest?Heart, 2004; 90:1114–1118.
49.
MenzebachA, BergtS, von WaldthausenP, DinuC, Nöldge-SchomburgG, VollmarB. A comprehensive study of survival, tissue damage, and neurological dysfunction in a murine model of cardiopulmonary resuscitation after potassium-induced cardiac arrest. Shock, 2010; 33:189–196.
50.
SafarP, StezoskiW, NemotoEM. Amelioration of brain damage after 12 minutes' cardiac arrest in dogs. Arch Neuro, 1976; 33:91–95.
51.
ShaffnerDH, EleffSM, BrambrinkAM, SugimotoH, IzutaM, KoehlerRC, TraystmanRJ. Effect of arrest time and cerebral perfusion pressure during cardiopulmonary resuscitation on cerebral blood flow, metabolism, adenosine triphosphate recovery, and pH in dogs. Crit Care Med, 1999; 27:1335–1342.
52.
LiD, ShaoZ, Vanden HoekTL, BrorsonJR. Reperfusion accelerates acute neuronal death induced by simulated ischemia. Exp Neurol, 2007; 206:280–287.
53.
GarciaJH, LiuKF, HoKL. Neuronal necrosis after middle cerebral artery occlusion in Wistar rats progresses at different time intervals in the caudoputamen and the cortex. Stroke, 1995; 26:636–642discussion 643.
54.
BabuCS, RamanathanM. Post-ischemic administration of nimodipine following focal cerebral ischemic-reperfusion injury in rats alleviated excitotoxicity, neurobehavioural alterations and partially the bioenergetics. Int J Dev Neurosci, 2011; 29:93–105.
55.
Martin-VillalbaA, HahneM, KleberS, VogelJ, FalkW, SchenkelJ, KrammerPH. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ, 2001; 8:679–686.
56.
TuttolomondoA, Di SciaccaR, Di RaimondoD, ArnaoV, RendaC, PintoA, LicataG. Neuron protection as a therapeutic target in acute ischemic stroke. Curr Top Med Chem., 2009; 9:1317–1334.
57.
SawitzkiB, AmersiF, RitterT, FisserM, ShenXD, KeB, BusuttilR, VolkHD, Kupiec-WeglinskiJW. Upregulation of Bag-1 by ex vivo gene transfer protects rat livers from ischemia/reperfusion injury. Hum Gene Ther, 2002; 13:1495–1504.
58.
RaisonJK. The influence of temperature-induced phase changes on the kinetics of respiratory and other membrane-associated enzyme systems. J Bioenerg, 1973; 4:285–309.
59.
BehringerW, SafarP, WuX, KentnerR, RadovskyA, KochanekPM, DixonCE, TishermanSA. Survival without brain damage after clinical death of 60–120 mins in dogs using suspended animation by profound hypothermia. Crit Care Med, 2003; 31:1523–1531.
60.
OhtaH, TeraoY, ShintaniY, KiyotaY. Therapeutic time window of post-ischemic mild hypothermia and the gene expression associated with the neuroprotection in rat focal cerebral ischemia. Neurosci Res, 2007; 57:424–433.
61.
HamannGF, BurggrafD, MartensHK, LiebetrauM, JägerG, WunderlichN, DeGeorgiaM, KriegerDW. Mild to moderate hypothermia prevents microvascular basal lamina antigen loss in experimental focal cerebral ischemia. Stroke, 2004; 35:764–769.
62.
DarberaL, ChenouneM, LidourenF, GhalehB, CohenMV, DowneyJM, BerdeauxA, TissierR. Adenosine and opioid receptors do not trigger the cardioprotective effect of mild hypothermia. J Cardiovasc Pharmacol Ther, 2011, 10.1177/1074248411412969.
63.
MeybohmP, GruenewaldM, ZacharowskiKD, AlbrechtM, LuciusR, FöselN, HenslerJ, ZittaK, BeinB. Mild hypothermia alone or in combination with anesthetic post-conditioning reduces expression of inflammatory cytokines in the cerebral cortex of pigs after cardiopulmonary resuscitation. Crit Care, 2010; 14:R21.
64.
Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med, 2002; 346:549–556Erratum in: N Engl J Med 2002;346:1756.
65.
HansenTN, HaworthRA, SouthardJH. Warm and cold ischemia result in different mechanisms of injury to the coronary vasculature during reperfusion of rat hearts. Transplant Proc, 2000; 32:15–18.
66.
RauenU, PetratF, SustmannR, de GrootH. Iron-induced mitochondrial permeability transition in cultured hepatocytes. J Hepato, 2004; 40:607–615.
67.
ZaoualiMA, Ben AbdennebiH, Padrissa-AltésS, Mahfoudh-BoussaidA, Roselló-CatafauJ. Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin Pharmacother, 2010; 11:537–555.
68.
Al-FageehMB, SmalesCM. Control and regulation of the cellular responses to cold shock: The responses in yeast and mammalian systems. Biochem J, 2006; 397:247–259.
69.
HaysLM, CroweJH, WolkersW, RudenkoS. Factors affecting leakage of trapped solutes from phospholipid vesicles during thermotropic phase transitions. Cryobiology, 2001; 42:88–102.
70.
DrexlerKE. Molecular engineering: An approach to the development of general capabilities for molecular manipulation. Proc Natl Acad Sci USA, 1981; 78:5275–5278.
71.
MerkleRC. The technical feasibility of cryonics. Med Hypotheses, 1992; 39:6–16.
